Bhagiradha Chemicals & Industries Limited(BHAGCHEM.NS)
No price history available.
Key financial summary
Financials in INR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | INRm | 2,457 | 3,175 | 4,346 | 5,020 | 4,075 | 4,405 | 5,359 | 5,359 |
| Operating profit | INRm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | INRm | 65 | 233 | 357 | 452 | 182 | 139 | 182 | 182 |
| EPS reported | INR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | INR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | INR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | INR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | INRm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | INRm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | INRm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | INR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | INR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in INR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Bhagiradha Chemicals & Industries Limited is an Indian-based enterprise primarily involved in the production and sale of various agrochemicals. Its comprehensive product portfolio includes a variety of insecticides such as chlorpyrifos, chlorpyrifos-methyl, diafenthiuron, fipronil, dinotefuran, thiamethoxam, pymetrozine, and imidacloprid. The company also manufactures fungicides, including azoxystrobin, and a selection of herbicides like triclopyr, cloquintocet-mexyl, and clodinafop-propargyl. Furthermore, it supplies specialized intermediate chemicals such as 2,6-dichloroaniline. In addition to its own products, Bhagiradha Chemicals provides contract manufacturing services. With a substantial global footprint, the company exports its offerings to numerous countries including the United States, Brazil, Colombia, Argentina, Mexico, Costa Rica, Germany, the United Kingdom, France, Portugal, Chile, Italy, Belgium, Israel, Turkey, Iran, Indonesia, Taiwan, Malaysia, New Zealand, the United Arab Emirates, Korea, and Australia. Established in 1993, its headquarters are located in Hyderabad, India.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Bhagiradha Chemicals & Industries Limited (BHAGCHEM.NS)
No price history available.
Not enough data to calculate KvantraRank
Based on consensus from external analysts. Not Kvantra's opinion.
Bhagiradha Chemicals & Industries Limited is an Indian-based enterprise primarily involved in the production and sale of various agrochemicals. Its comprehensive product portfolio includes a variety of insecticides such as chlorpyrifos, chlorpyrifos-methyl, diafenthiuron, fipronil, dinotefuran, thiamethoxam, pymetrozine, and imidacloprid. The company also manufactures fungicides, including azoxystrobin, and a selection of herbicides like triclopyr, cloquintocet-mexyl, and clodinafop-propargyl. Furthermore, it supplies specialized intermediate chemicals such as 2,6-dichloroaniline. In addition to its own products, Bhagiradha Chemicals provides contract manufacturing services. With a substantial global footprint, the company exports its offerings to numerous countries including the United States, Brazil, Colombia, Argentina, Mexico, Costa Rica, Germany, the United Kingdom, France, Portugal, Chile, Italy, Belgium, Israel, Turkey, Iran, Indonesia, Taiwan, Malaysia, New Zealand, the United Arab Emirates, Korea, and Australia. Established in 1993, its headquarters are located in Hyderabad, India.